Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes. In the field of endoscopy, the company has introduced single-use bronchoscopes and duodenoscopes designed to eliminate the need for time-consuming reprocessing and to address concerns over device-associated infections. Ambu also offers patient monitoring equipment and accessories, complementing its core devices with integrated solutions for intensive care units and perioperative settings.
Headquartered in Ballerup, Denmark, Ambu maintains manufacturing facilities in Europe, Asia and North America and distributes its products through subsidiaries and partners in over 100 countries. The company’s global reach enables it to serve markets in Europe, North America, Latin America and the Asia-Pacific region, with dedicated sales and support teams ensuring regulatory compliance and customer training. This international footprint underscores Ambu’s commitment to bringing single-use technology to healthcare providers worldwide.
Founded in 1937, Ambu derived its name from the original “Artificial Manual Breathing Unit” it pioneered. Over the decades, the company has expanded its portfolio through in-house innovation and strategic acquisitions, cementing its reputation as a leader in disposable medical devices. With research and development centers in Denmark and abroad, Ambu continues to invest in new technologies aimed at improving patient outcomes, reducing infection risks and supporting healthcare professionals in fast-paced clinical environments.
AI Generated. May Contain Errors.
